Riskpilot← Back to searchSign inGet full accessTEVA DENMARK A/S
A/SActiveCVR 29634076Vandtårnsvej 83AWholesale of pharmaceutical and medical goods · NACE 4646Est. 200637 employeeswww.tevapharm.dk
Revenue 2024
DKK 632,2M
+22% vs 2023
EBITDA margin
12.4%
+14% vs 2023
Equity ratio
51.2%
Financial strength
Net profit 2024
DKK 57,4M
+23% vs 2023
| Revenue | DKK 632,2M | +22% |
| EBITDA | DKK 78,6M | +14% |
| Net profit | DKK 57,4M | +23% |
| Total assets | DKK 325,7M | -13% |
| Equity | DKK 166,9M | -20% |
| Employees | 37 | — |
Legal name
TEVA DENMARK A/S
CVR number
29634076
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. juni 2006
Share capital
DKK 501.000
Employees
37 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af (i) to medlemmer af bestyrelsen i forening, (ii) af et medlem af bestyrelsen sammen med et medlem af direktionen, (iii) af to direktører i forening eller (iv) af den samlede bestyrelse.
Company purpose
Selskabets formål er : (a) at importere/eksportere, registrere, markedsføre og distribuere lægemidler og relaterede produkter til brug for mennesker eller dyr, (b) at stifte, have andel i, administrere, rådgive, auditere, samarbejde med, forestå ledelsen af og yde tjenester til andre selskaber og virksomheder, samt finansiere andre selskaber og virksomheder, og (c) at udføre enhver aktivitet, som måtte være relateret til eller befordrende for ovenstående i bredest mulige forstand. Selskabet kan stille sikkerhed, pantsætte aktiver, garantere for opfyldelsen af samt forpligte sig særskilt eller på anden vis for betalingen af koncernselskabers og/eller tredjemands gæld.
Address
Vandtårnsvej 83A
Phone
+4544985511
Email
info@tevapharm.dk
Website
www.tevapharm.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.315 | 28.277 | 30.824 | 34.809 | 31.213 | 42.675 | 586.459 | 563.009 | 529.350 | 384.312 | 411.374 | 517.926 | 632.169 |
| Staff expenses | -22.014 | -22.554 | -23.745 | -27.087 | -25.096 | -35.216 | -39.922 | -34.089 | -35.167 | -32.658 | -32.695 | -31.869 | -37.257 |
| EBITDA | 4.301 | 5.722 | 7.079 | 7.722 | 6.116 | 7.459 | 61.925 | 40.066 | 49.014 | 57.164 | 53.616 | 68.979 | 78.592 |
| Depreciation & amort. | -417 | -591 | -1.342 | -41 | -36 | -204 | -36.266 | -29.617 | -30.392 | -16.155 | -14.338 | -11.315 | -5.020 |
| EBIT | 3.885 | 5.131 | 5.737 | 7.681 | 6.080 | 7.255 | 25.659 | 10.449 | 18.622 | 41.009 | 39.278 | 57.664 | 73.572 |
| Net financials | -1.634 | -887 | -765 | -830 | -119 | -3.387 | -3.473 | -1.068 | -42.067 | -176 | 15.120 | 2.661 | 1.801 |
| Profit before tax | 2.250 | 4.244 | 4.972 | 6.851 | 5.961 | 3.868 | 22.186 | 9.381 | -23.445 | 40.833 | 54.398 | 60.325 | 75.373 |
| Tax | 612 | 1.120 | 1.230 | 2.443 | 1.164 | 1.279 | 7.525 | 5.994 | 5.850 | 10.310 | 13.164 | 13.622 | 17.951 |
| Net profit | 1.638 | 3.124 | 3.742 | 4.408 | 4.797 | 2.589 | 14.661 | 3.387 | -29.295 | 30.523 | 41.234 | 46.703 | 57.422 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 141.128 | 121.824 | 127.089 | 146.892 | 132.489 | 234.422 | 364.176 | 331.706 | 282.988 | 296.657 | 274.911 | 376.225 | 325.745 |
| Equity | 34.980 | 38.105 | 41.847 | 46.255 | 51.052 | 53.640 | 123.894 | 127.281 | 142.653 | 173.176 | 199.728 | 209.431 | 166.853 |
| Long-term debt | 58.937 | 58.937 | 58.839 | 58.879 | 22.384 | 22.322 | 0 | 1.130 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 47.211 | 24.783 | 26.403 | 41.758 | 59.054 | 158.280 | 239.931 | 203.295 | 140.335 | 123.481 | 75.183 | 166.794 | 158.892 |
| Total debt | 106.147 | 83.719 | 85.242 | 100.637 | 81.437 | 180.602 | 240.282 | 204.425 | 140.335 | 123.481 | 75.183 | 166.794 | 158.892 |
EBITDA margin
12.4%
This company
15.8%
Market median
-22% vs market
20122024
Equity ratio
51.2%
This company
38.2%
Market median
+34% vs market
20122024
Return on equity
34.4%
This company
18.4%
Market median
+87% vs market
20122024
Net profit margin
9.1%
This company
8.1%
Market median
+12% vs market
20122024
Asset turnover
1.94×
This company
1.12×
Market median
+73% vs market
20122024
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EG Management | Management | 2010 | — | — |
SJ Management | Management | 2006 | — | — |
MN Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
LJ Management | Management | 2008 | — | — |
KV Management | Management | 2014 | — | — |
BL Management | Management | 2014 | — | — |
BP Management | Management | 2018 | — | — |
AO Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2006 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TEVA DENMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emile Gérardus Wilhelmus Hendr icus Loof | Management | 0 companies |
| Simon James Clark | Management | 0 companies |
| Morten Nielsen | Chief Executive Officer | 0 companies |
| Lone Juul Darket | Management | 0 companies |
| Kim Vallentin Peetz | Management | 0 companies |
| Betina Liliendal | Management | 0 companies |
| Bjarne Palle Niemi | Management | 0 companies |
| Arni Olafur Asgeirsson | Management | 0 companies |
| Peter Mikael Burestedt | Chairman | 0 companies |
| Gertjan Noordermeer | Board of Directors | 0 companies |
| Mirko Vonk | Board of Directors | 0 companies |
| Johannes Adrianus de Heus | Chairman | 0 companies |
| Boris Niklas Döbler | Board of Directors | 0 companies |
| Henri Pieter Josephus Henrichs | Chairman | 0 companies |
| Helle Grinderslev Kramp | Board of Directors | 0 companies |
| Theodorus Jacobus Andriessen | Chairman | 0 companies |
| Tim Oreskovic | Board of Directors | 0 companies |
| Olöf Thorhallsdottir | Chairman | 0 companies |